We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




MRI Identifies Parkinson’s in Patients at Risk of Dementia

By HospiMedica International staff writers
Posted on 26 Mar 2014
According to new research out of Canada, it may now be possible to identify which first-stage Parkinson’s disease (PD) patients who will go on to develop dementia. More...


The study was conducted at the Institut Universitaire de Geriatrie de Montreal (Montreal, QC, Canada) by Dr. Oury Monchi, PhD, and his postdoctoral student, Dr. Alexandru Hanganu, MD, PhD, both of whom are affiliated with Universite de Montreal. Their findings were published in the February 2014 issue of the journal Brain.

Although PD is typically tied to motor difficulties such as trembling or rigidity or trembling, individuals with this disease basically have a six times greater chance of developing dementia compared to the rest of the population. In this first longitudinal study in this field, 32 patients in the first stages of PD were followed for 20 months. Some of the patients had mild cognitive deficiencies while others did not. A control group of 18 healthy people were also monitored.

“Using magnetic resonance imaging [MRI], we found thinning in certain cortical areas as well as subcortical atrophy in the grey matter of subjects with mild cognitive impairments. Thanks to our longitudinal approach, we were able to observe that this thinning speeds up in conjunction with the increase in cognitive problems,” explained Dr. Monchi. This specific brain deterioration combined with the early presence of mild cognitive impairments could serve as markers for the development of dementia.

Dr. Monchi stressed the significance of these findings. “This study opens the door to further research, for example, on medication or on nonpharmacological approaches such as transcranial magnetic stimulation. It’s important for these patients to be identified very quickly before they develop dementia so that a therapeutic approach can be adapted to their specific needs.”

Related Links:

Institut Universitaire de Geriatrie de Montreal



Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Enteral Feeding Pump
SENTINELplus
Infrared Digital Thermometer
R1B1
Gold Member
Electrode Solution and Skin Prep
Signaspray
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.